ARCUTIS
developments are the most meaningful for our organisation is a big thing I have to wrestle with. The landscape is constantly changing, last year it was Gen AI, this year it’ s Agentic AI.”
When adopting technology, Arcutis again seeks to ensure cohesion between IT investments and business goals. The team constantly measures and evaluates return on investment, going back to previous adoptions to ensure optimal current use.
In speaking about industry challenges in general, Rajvir thinks that one of the critical challenges- in addition to cybersecurity- is the challenge of drug discovery and development. Nine out of ten drugs developed never make it to the commercialisation stage, failing the clinical trial process. Drugs that make it can take anywhere between 10 to 12 years to get to commercial state product. Naturally, this is a costly, risky and timeconsuming process.
14 arcutis. com